Alzamend Neuro (ALZN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.30, +1.56% vs the prior close of $1.28.
- Volume 14.96K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ALZN rises 1.6% to $1.30. Closed at $1.30, +1.56% vs the prior close of $1.28. Day range $1.25–$1.34, opened at $1.29.
ALZN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ALZN rises 1.6% to $1.30
- Closed at $1.30, +1.56% vs the prior close of $1.28. Day range $1.25–$1.34, opened at $1.29.
- Volume was 14.96K shares, 0.2x its 50-day average of 93.85K — lighter than usual.
- Price is -18.5% vs its 50-day average ($1.59) and -14.8% vs its 200-day average ($1.53).
- 52-week range $0.84–$2.68; today's close sits at 25% of that range, 51.5% below the 52-week high.
Oct 15, 2026 — ALZN slides 5.2% to $1.28, a 1-month low
- Closed at $1.28, -5.19% vs the prior close of $1.35. Day range $1.28–$1.34, opened at $1.32.
- Volume was 15.00K shares, 0.2x its 50-day average of 94.42K — lighter than usual.
- Price is -19.8% vs its 50-day average ($1.60) and -16.2% vs its 200-day average ($1.53).
- 52-week range $0.84–$2.68; today's close sits at 24% of that range, 52.2% below the 52-week high.
Oct 14, 2026 — ALZN ends flat (+0.0%) to $1.35
- Closed at $1.35, +0.00% vs the prior close of $1.35. Day range $1.31–$1.40, opened at $1.31.
- Volume was 23.20K shares, 0.2x its 50-day average of 96.95K — lighter than usual.
- Price is -15.6% vs its 50-day average ($1.60) and -11.9% vs its 200-day average ($1.53).
- 52-week range $0.84–$2.68; today's close sits at 28% of that range, 49.6% below the 52-week high.
Oct 13, 2026 — ALZN jumps 3.1% to $1.35
- Closed at $1.35, +3.05% vs the prior close of $1.31. Day range $1.30–$1.43, opened at $1.43.
- Volume was 18.00K shares, 0.2x its 50-day average of 97.16K — lighter than usual.
- Price is -15.7% vs its 50-day average ($1.60) and -12.0% vs its 200-day average ($1.53).
- 52-week range $0.84–$2.68; today's close sits at 28% of that range, 49.6% below the 52-week high.
Oct 12, 2026 — ALZN dips 2.2% to $1.31, a 1-month low, 5 down days in a row
- Closed at $1.31, -2.24% vs the prior close of $1.34. Day range $1.31–$1.43, opened at $1.40.
- Volume was 17.00K shares, 0.2x its 50-day average of 97.31K — lighter than usual.
- Price is -18.2% vs its 50-day average ($1.60) and -14.8% vs its 200-day average ($1.54).
- 52-week range $0.84–$2.68; today's close sits at 26% of that range, 51.1% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — ALZN ends flat (+0.0%) to $1.34, 4 down days in a row
- Closed at $1.34, +0.00% vs the prior close of $1.34. Day range $1.34–$1.43, opened at $1.43.
- Volume was 13.30K shares, 0.1x its 50-day average of 97.56K — lighter than usual.
- Price is -16.3% vs its 50-day average ($1.60) and -13.1% vs its 200-day average ($1.54).
- 52-week range $0.84–$2.68; today's close sits at 27% of that range, 50.0% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — ALZN dips 2.2% to $1.34, 3 down days in a row
- Closed at $1.34, -2.19% vs the prior close of $1.37. Day range $1.22–$1.35, opened at $1.32.
- Volume was 7.00K shares, 0.1x its 50-day average of 97.80K — lighter than usual.
- Price is -16.3% vs its 50-day average ($1.60) and -13.3% vs its 200-day average ($1.55).
- 52-week range $0.84–$2.68; today's close sits at 27% of that range, 50.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ALZN ends flat (+0.0%) to $1.37
- Closed at $1.37, +0.00% vs the prior close of $1.37. Day range $1.34–$1.42, opened at $1.37.
- Volume was 18.80K shares, 0.2x its 50-day average of 98.12K — lighter than usual.
- Price is -14.4% vs its 50-day average ($1.60) and -11.6% vs its 200-day average ($1.55).
- 52-week range $0.84–$2.68; today's close sits at 29% of that range, 48.9% below the 52-week high.
Oct 6, 2026 — ALZN dips 2.8% to $1.37
- Closed at $1.37, -2.84% vs the prior close of $1.41. Day range $1.34–$1.43, opened at $1.43.
- Volume was 32.10K shares, 0.3x its 50-day average of 98.22K — lighter than usual.
- Price is -14.4% vs its 50-day average ($1.60) and -11.8% vs its 200-day average ($1.55).
- 52-week range $0.84–$2.68; today's close sits at 29% of that range, 48.9% below the 52-week high.
Oct 5, 2026 — ALZN rises 2.9% to $1.41
- Closed at $1.41, +2.92% vs the prior close of $1.37. Day range $1.38–$1.48, opened at $1.38.
- Volume was 25.40K shares, 0.3x its 50-day average of 98.70K — lighter than usual.
- Price is -11.8% vs its 50-day average ($1.60) and -9.5% vs its 200-day average ($1.56).
- 52-week range $0.84–$2.68; today's close sits at 31% of that range, 47.4% below the 52-week high.
Oct 2, 2026 — ALZN jumps 4.2% to $1.37 on 2.5x normal volume
- Closed at $1.37, +4.18% vs the prior close of $1.32. Day range $1.20–$1.48, opened at $1.41.
- Volume was 236.40K shares, 2.5x its 50-day average of 94.67K — unusually heavy trading.
- Price is -14.3% vs its 50-day average ($1.60) and -12.3% vs its 200-day average ($1.56).
- 52-week range $0.84–$2.68; today's close sits at 29% of that range, 48.9% below the 52-week high.
ALZN latest news & SEC filings
Every SEC filing by or about ALZN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 31, 2026:
- Net income: -$3.03M (prior year -$2.70M) (loss widened vs Jul 31, 2025)
- Diluted EPS: -$0.68 (prior year -$1.28) (loss narrowed vs Jul 31, 2025)
Aug 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ault Milton C Iii sold 2,000 shares at $1.56 (≈$3.12K) on Aug 26, 2026
- Ault Milton C Iii sold 2,000 shares at $1.56 (≈$3.12K) on Aug 26, 2026
- Ault Milton C Iii sold 2,000 shares at $1.56 (≈$3.12K) on Aug 26, 2026
- Ault Milton C Iii sold 2,000 shares at $1.56 (≈$3.12K) on Aug 26, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 31, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Ault Milton C Iii bought 2,000 shares at $1.03 (≈$2.06K) on Apr 14, 2026
- Ault Milton C Iii bought 108,388 shares at $1.00 (≈$108.39K) on Apr 14, 2026
- Ault Milton C Iii bought 2,000 shares at $1.03 (≈$2.06K) on Apr 14, 2026
- Ault Milton C Iii bought 108,388 shares at $1.00 (≈$108.39K) on Apr 14, 2026
- Ault Milton C Iii bought 2,000 shares at $1.03 (≈$2.06K) on Apr 14, 2026
- Ault Milton C Iii bought 108,388 shares at $1.00 (≈$108.39K) on Apr 14, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 31, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Ault Milton C Iii bought 2,000 shares at $1.03 (≈$2.06K) on Apr 14, 2026
- Ault Milton C Iii bought 108,388 shares at $1.00 (≈$108.39K) on Apr 14, 2026
- Ault Milton C Iii bought 2,000 shares at $1.03 (≈$2.06K) on Apr 14, 2026
- Ault Milton C Iii bought 108,388 shares at $1.00 (≈$108.39K) on Apr 14, 2026
- Ault Milton C Iii bought 2,000 shares at $1.03 (≈$2.06K) on Apr 14, 2026
- Ault Milton C Iii bought 108,388 shares at $1.00 (≈$108.39K) on Apr 14, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 21, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 20, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 4, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 3.02 — Sold unregistered shares.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Jul 22, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Apr 30, 2026:
- Net income: -$8.77M (prior year -$4.51M) (loss widened vs Apr 30, 2025)
- Diluted EPS: -$2.63 (prior year -$11.32) (loss narrowed vs Apr 30, 2025)
Jul 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade ALZN
- Last results release: Jul 23, 2025 (8-K Item 2.02). Previous ones: Dec 12, 2024, Mar 16, 2023. Based on that rhythm, the next report is likely around Oct 22, 2025 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.66% (largest 24.0%). That is a volatile stock.
- Liquidity: about 62.21K shares (≈$80.88K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.30 vs a range of $0.84–$2.68 (25% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:9 on May 12, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 5 sales; latest: Milton C Iii Ault sold 2,000 shares on Aug 26, 2026.
- Latest filings: 8-K Sep 29, 2026; 10-Q Sep 10, 2026; 8-K Aug 3, 2026.
- Share count: 4.83M shares outstanding (Sep 10, 2026), +53.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ALZN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.29 | 1.34 | 1.25 | 1.30 | 14.96K |
| Oct 15, 2026 | 1.32 | 1.34 | 1.28 | 1.28 | 15.00K |
| Oct 14, 2026 | 1.31 | 1.40 | 1.31 | 1.35 | 23.20K |
| Oct 13, 2026 | 1.43 | 1.43 | 1.30 | 1.35 | 18.00K |
| Oct 12, 2026 | 1.40 | 1.43 | 1.31 | 1.31 | 17.00K |
| Oct 9, 2026 | 1.43 | 1.43 | 1.34 | 1.34 | 13.30K |
| Oct 8, 2026 | 1.32 | 1.35 | 1.22 | 1.34 | 7.00K |
| Oct 7, 2026 | 1.37 | 1.42 | 1.34 | 1.37 | 18.80K |
| Oct 6, 2026 | 1.43 | 1.43 | 1.34 | 1.37 | 32.10K |
| Oct 5, 2026 | 1.38 | 1.48 | 1.38 | 1.41 | 25.40K |
| Oct 2, 2026 | 1.41 | 1.48 | 1.20 | 1.37 | 236.40K |
| Oct 1, 2026 | 1.72 | 1.72 | 1.26 | 1.32 | 150.60K |
| Sep 30, 2026 | 1.84 | 1.84 | 1.73 | 1.73 | 21.70K |
| Sep 29, 2026 | 1.75 | 1.85 | 1.74 | 1.82 | 49.50K |
| Sep 28, 2026 | 1.80 | 1.92 | 1.73 | 1.73 | 83.80K |
| Sep 25, 2026 | 1.90 | 1.90 | 1.76 | 1.83 | 23.30K |
| Sep 24, 2026 | 1.90 | 1.93 | 1.82 | 1.82 | 150.50K |
| Sep 23, 2026 | 1.93 | 1.95 | 1.93 | 1.94 | 45.80K |
| Sep 22, 2026 | 1.93 | 1.94 | 1.90 | 1.94 | 91.20K |
| Sep 21, 2026 | 1.89 | 1.94 | 1.87 | 1.94 | 206.70K |
About Alzamend Neuro
Alzamend Neuro (ALZN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ATLANTA, GA. State of incorporation: DE. Fiscal year ends April 30. SEC CIK 1677077.
ALZN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Milton C Iii Ault | Director | Aug 31, 2026 |
| Capital Group, Inc. Ault | Director by deputization | Aug 20, 2026 |
| Lending, Llc Ault | Director by deputization | Aug 20, 2026 |
| Mark Gustafson | Director | Aug 4, 2026 |
| William B. Horne | Director | Aug 4, 2026 |
| Data, Inc. Hyperscale | Director by deputization | Aug 20, 2026 |
| Stephan Jackman | Chief Executive Officer | Aug 4, 2026 |
| Lynne Fahey Mcgrath | Director | Oct 24, 2025 |
| Henry Carl Nisser | EVP and General Counsel | Aug 4, 2026 |
| Jeffrey Oram | Director | Aug 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Stephan Jackman | Chief Executive Officer | Aug 4, 2026 |
| David J Katzoff | Chief Financial Officer | Aug 4, 2026 |
| Henry Carl Nisser | EVP and General Counsel | Aug 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 26, 2026 | Milton C Iii Ault | Sale | 2,000 | $1.56 |
| Aug 26, 2026 | Milton C Iii Ault | Sale | 2,000 | $1.56 |
| Aug 26, 2026 | Milton C Iii Ault | Sale | 2,000 | $1.56 |
| Aug 26, 2026 | Milton C Iii Ault | Sale | 2,000 | $1.56 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 108,388 | $1.00 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 108,388 | $1.00 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 108,388 | $1.00 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 108,388 | $1.00 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 2,000 | $1.03 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 108,388 | $1.00 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 2,000 | $1.03 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 108,388 | $1.00 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 2,000 | $1.03 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 108,388 | $1.00 |
| Apr 14, 2026 | Milton C Iii Ault | Buy | 2,000 | $1.03 |
ALZN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Apr 30, 2026 | — | $-8.77M | -2.63 | $-8.07M |
| Apr 30, 2025 | — | $-4.51M | -11.32 | $-6.57M |
| Apr 30, 2024 | — | $-9.95M | -132.33 | $-8.27M |
| Apr 30, 2023 | — | $-14.88M | -22.89 | $-8.92M |
| Apr 30, 2022 | — | $-12.36M | -0.14 | $-6.61M |
Latest balance sheet: total assets $8.54M, total liabilities $2.74M, cash $7.59M (as of Jul 31, 2026).
ALZN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 23, 2025 | 8-K Item 2.02 (results) | $3.01 |
| Dec 12, 2024 | 8-K Item 2.02 (results) | $10.71 |
| Mar 16, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ALZN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.